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Abstract
Introduction
Post-treatment Quality of Life (QOL) is considered an important outcome in cancer patients. A
number of questionnaire tools have been designed for its assessment. University of Washington
Quality of Life (UW QOL) questionnaire version four is a reliable tool for assessment of post-
treatment QOL in oral squamous cell carcinoma (OSCC) patients. Our aim was to identify the
post-treatment problems faced by OSCC patients and to assess the impact of clinical factors
affecting post-treatment QOL by using UW QOL (version four) questionnaire.
Methods
The study was conducted on 59 patients with OSCC who were treated with curative intent at
Patel Hospital, Karachi from August 2015 to September 2015. Patients were asked to fill the UW
QOL questionnaire (version four) on their follow-up visit.
Results
Overall mean composite QOL score was 66.59 ± 16.98. Chewing and saliva (dryness of mouth)
had the lowest scores (38.98 ± 37.2 and 56.78 ± 41.4, respectively) among all domains while pain
and anxiety had the highest scores (80.93 ± 20.4 and 79.66 ± 29.8, respectively). Patients having
tumors of the tongue, late stage (III and IV) tumors, and restricted mouth opening had
significantly lower mean composite QOL scores. Patients with tongue tumors revealed
significantly lower scores for pain, swallowing, mood, and anxiety. Patients with late-stage
tumors showed significantly lower scores for chewing, swallowing, taste, saliva, appearance,
anxiety, and recreation. Patients with restricted mouth opening had significantly lower scores
for pain, speech, appearance, recreation, and anxiety domains.
Conclusion
Different clinical features have different impacts on QOL in terms of problems faced by the
patients. Features having a significant effect should be identified, and measures focused on
most relevant problems should be employed in order to improve the post-treatment QOL.
1 2 3 4
5 6 7
 Open Access OriginalArticle  DOI: 10.7759/cureus.3904
How to cite this article
Abbas S, Tariq M U, Raheem A, et al. (January 16, 2019) Assessment of Factors Affecting Quality of Life
in Oral Squamous Cell Carcinoma Patients Using University of Washington Quality of Life Questionnaire.
Cureus 11(1): e3904. DOI 10.7759/cureus.3904
Categories: Otolaryngology, Plastic Surgery, Oncology
Keywords: oral, squamous cell carcinoma, post-treatment, quality of life, score
Introduction
Oral squamous cell carcinoma (OSCC) is a leading cause of cancer-related morbidity and
mortality with the global annual incidence approaching 500,000 [1]. Annual OSCC incidence in
Pakistan is 14,000 and urban Karachi has one of the highest incidences of OSCC worldwide [2].
Approximately 50% of these patients present with advanced stage (III or IV) disease and this
translates into poor outcomes in survival pattern and the five-year survival rate is 20% [3].
Those who survive have varying degrees of compromised quality of life (QOL) [4]. Radiation to
head and neck region has long-term implications such as limited mouth opening and dryness in
the oral cavity [5]. The combined effect is significantly compromised speech and swallowing
ability culminating in poor nutritional status and inability to return to a fully functional
lifestyle.
There is a dire need to understand the functional limitations of these patients as a result of the
disease process and subsequent interventions [6]. Significant evidence exists in favor of QOL as
a predictor of cancer survivorship among OSCC patients [7]. Hence, disease-free survival (DFS)
and improved QOL are now considered as combined endpoints in these patients. The last
decade has witnessed intense focus on OSCC survivors and much effort has been put to identify
the factors affecting the QOL. This would help in implementing therapies and measures aimed
at improving the outcome.
Various QOL questionnaires have been used to estimate the outcomes in OSCC. University of
Washington Quality of Life (UW QOL) questionnaire version four is a simple, brief and well-
validated questionnaire that is globally employed in OSCC patients [8]. The incorporation of
two important psychosocial factors (mood and anxiety) has made it a comprehensive tool to
assess the outcome [9].
There is a paucity of literature from South Asia regarding QOL where OSCC is virtually
endemic. This particular study aims at addressing the factors affecting post-treatment QOL in
OSCC patients from a tertiary care hospital of Karachi, Pakistan. So far, no study has
evaluated post-treatment QOL using the UW QOL questionnaire in Pakistani population.
Identification of such possible prognosticators may help us start specific therapies aimed at
improving the outcomes in these patients.
Materials And Methods
This cross-sectional study was conducted at our Patel Hospital, Karachi from August 2015 to
September 2015. This study was approved by the hospital’s ethics committee (approval number:
44). A total of 120 patients with biopsy-proven OSSC were treated at our department during this
period. Patients who underwent surgical excision with or without radiotherapy and/or
chemotherapy with curative intent were included in the study. Patients treated with palliative
intent and those treated with chemotherapy alone or chemoradiotherapy without surgery were
excluded. Fifty-nine patients were finally selected in the study.
UW QOL questionnaire (Version 4) was employed as the questionnaire tool which is a self-
reporting 12 point scale addressing pain, appearance, activity, recreation, swallowing, chewing,
speech, shoulder function, taste, saliva, mood, and anxiety [10]. It also takes into consideration
the most important issues faced by the patient over the last seven days. The responses from
patients were rated from 0 (worst) to 100 (best) and mean scores for an individual was
calculated. Patients with a higher mean score were interpreted to have a good outcome in terms
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of QOL.
In addition, there are two questions which address the patient’s perception about his/her well-
being. These are Health Related QOL (HR-QOL) and Global QOL (G-QOL). HR-QOL assesses the
overall health perception of the patient over the last seven days, while G-QOL assesses the
overall QOL of the patient over the last seven days. These responses are scored on a 6 point
Likert scale (ranging from very poor to outstanding). This purpose of the study was explained to
the patients during their follow-up visit. Written informed consent was obtained from the
patients. They were asked to fill out the questionnaire in a separate room and they were helped
in filling out their responses where required.
Demographic and treatment-related details were obtained from the head and neck cancer
database maintained at our department. The UW-QOL questionnaire related data was entered
and analyzed using IBM SPSS Statistics for Windows, Version 21.0. (IBM Corp., Armonk, NY,
US). The descriptive statistics were calculated for demographic variables in terms of mean ± SD.
Patients were divided into two age groups (≤47 years and >47 years) based on median age, i.e.,
47 years. Frequency and percentages were calculated for all categorical variables. Overall mean
composite scores of QOL, HR-QOL, and G-QOL were calculated by using multiple response
analysis. Seven factors were assessed for their impact on QOL in our patients. These include
patient’s age, pre-operative oral addiction habits, restricted mouth opening, tumor site, tumor
stage, treatment modality and follow up duration. The two-tailed analysis was conducted by
applying the Mann–Whitney U test and Kruskal Wallis test to check the significance of the
difference in mean QOL scores of each domain in different groups. The p-value of less than
0.05 was considered significant.
Results
Patient’s age ranged from 22 to 70 years with a mean ± SD of 47.9 ± 12.7 years. Male to female
ratio was 1.36:1. The follow-up duration ranged from six to seventy-three months with a mean
± SD of 33.4 ± 19.6 months. Overall mean composite QOL score was 66.59 ± 16.98. Chewing and
saliva had the lowest scores among all domains while pain and anxiety had the highest scores
(Figure 1).
FIGURE 1: Mean quality of life scores of different domains in
all patients.
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Patients having tumors of a tongue, late stage (III and IV) tumors, and restricted mouth
opening had significantly lower mean composite QOL scores when compared with patients
having tumors of cheek, early stage (I and II) tumors, and normal mouth opening, respectively.
Females, older patients (> 47 years), patients without oral addiction habits and without co-
morbid also had lower mean composite QOL scores when compared with patients males, older
patients, (> 47 years), patients with oral addiction habits and with co-morbid, respectively. But
the difference was statistically insignificant. Patients with single modality treatment had best
mean composite QOL scores and there was a linear drop in QOL scores as the number of
treatment modalities increased but statistical significance was not observed (Table 1).
Characteristics Frequency (%) Composite Score [Mean ± SD] p-value
Gender
Male 34 (57.63%) 68.01 ± 16.71
0.438
Female 25 (42.37%) 64.67 ± 17.51
Age
Up to 47 years 30 (50.85%) 68.26 ± 11.98
0.676
More than 47 years 29 (49.15%) 64.87 ± 21.04
Oral addiction habits
Yes 46 (77.97%) 67.89 ± 16.81
0.309
No 13 (22.03%) 62.02 ± 17.48
Co-morbids
Yes 15 (25.42%) 70.42 ± 22.96
0.143
No 44 (74.58%) 65.29 ± 14.51
Tumor site
Tongue (anterior 2/3) 29 (49.15%) 62.14 ± 15.31
0.029*
Cheek 30 (50.85%) 70.9 ± 17.65
Tumor stage
Early Stage (I and II) 27 (45.76%) 74.38 ± 11.67
0.002*
Late Stage (III and IV) 32 (54.24%) 60.02 ± 18.11
Mouth opening
Within normal limits 17 (28.81%) 75.61 ± 15.93
0.003*
Restricted mouth opening 42 (71.19%) 62.95 ± 16.17
Treatment modality
Surgery 10 (16.95%) 71.46 ± 15.44
0.148Surgery and radiotherapy 46 (77.97%) 66.8 ± 16.67
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Surgery, radio and chemotherapy 3 (5.08%) 47.22 ± 18.9
Follow up duration
Up to 1 year 8 (13.6%) 57.29 ± 19.2
0.2441 to 2 years 17 (28.8%) 67.15 ± 15.99
More than 2 years 34 (57.6%) 68.5 ± 16.7
TABLE 1: Comparison of Quality of Life Composite Score by Patient Characteristics
When patients with cheek tumors were compared with the patients having tongue tumors,
domain-wise comparison revealed significantly lower QOL scores for pain, swallowing, mood,
and anxiety (Table 2).
Domain Anterior 2/3 Tongue (n = 29) [Mean±SD] Cheek (n = 30) [Mean±SD] p-value
Pain 72.41 ± 13.93 85.83 ± 18.2 0.002*
Appearance 69.83 ± 27.04 70.83 ± 29.42 0.788
Activity 62.07 ± 25.55 65.83 ± 26.65 0.571
Recreation 66.38 ± 32.92 72.5 ± 32.4 0.436
Swallowing 58.62 ± 32.92 74.17 ± 34.42 0.029*
Chewing 39.66 ± 30.99 38.33 ± 33.95 0.826
Speech 62.93 ± 27.24 73.33 ± 14.58 0.137
Shoulder 72.41 ± 25.31 79.17 ± 24.64 0.236
Taste 65.52 ± 27.88 75 ± 27.07 0.122
Saliva 53.45 ± 33.22 62.5 ± 36.99 0.215
Mood 49.14 ± 24.53 70 ± 24.91 0.002*
Anxiety 73.28 ± 18.82 83.33 ± 21.1 0.019*
TABLE 2: Comparison of Quality of Life Domains by Tumor Site
Patients with late-stage tumors showed significantly lower QOL scores for chewing,
swallowing, taste, saliva, appearance, anxiety, and recreation, as compared to patients with
early-stage tumors (Table 3).
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Domain Early Stage (n = 27) [Mean ± SD] Late Stage (n = 33) [Mean ± SD] p-value
Pain 82.41 ± 16.72 76.56 ± 17.89 0.206
Appearance 78.7 ± 26.59 63.28 ± 27.67 0.023*
Activity 68.52 ± 23.61 60.16 ± 27.58 0.221
Recreation 78.7 ± 31.55 61.72 ± 31.74 0.026*
Swallowing 83.33 ± 21.93 52.34 ± 36.68 0.001*
Chewing 50 ± 24.02 29.69 ± 35.6 0.008*
Speech 74.07 ± 12.94 63.28 ± 26.93 0.089
Shoulder 80.56 ± 20.02 71.88 ± 28.22 0.305
Taste 77.78 ± 25.32 64.06 ± 28.35 0.045*
Saliva 69.44 ± 29.69 48.44 ± 36.99 0.036*
Mood 64.81 ± 28.81 55.47 ± 24.37 0.149
Anxiety 84.26 ± 18.54 73.44 ± 21 0.037*
TABLE 3: Comparison of Quality of Life Domains by Tumor Stage
In comparison to patients with normal mouth opening, patients with restricted mouth opening
had significantly lower scores for pain, speech, appearance, recreation, and anxiety domains
(Table 4).
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Domain Within Normal Limits (n = 17) [Mean ±SD]
Restricted Mouth Opening (n = 42) [Mean ±
SD] p-value
Pain 88.24 ± 15.61 75.6 ± 17.01 0.01*
Appearance 86.76 ± 17.94 63.69 ± 28.8 0.004*
Activity 69.12 ± 28.68 61.9 ± 24.84 0.385
Recreation 86.76 ± 25.18 62.5 ± 32.78 0.004*
Swallowing 72.06 ± 34.1 64.29 ± 34.55 0.374
Chewing 52.94 ± 37.38 33.33 ± 28.51 0.052
Speech 80.88 ± 20.78 63.1 ± 20.83 0.004*
Shoulder 80.88 ± 27.29 73.81 ± 24.04 0.152
Taste 64.71 ± 36.51 72.62 ± 23.3 0.670
Saliva 66.18 ± 37.44 54.76 ± 34.14 0.190
Mood 70.59 ± 25.36 55.36 ± 26.21 0.043*
Anxiety 88.24 ± 15.61 74.4 ± 21.02 0.013*
TABLE 4: Comparison of Quality of Life Domains by Status of Mouth Opening
Interestingly, patients without pre-operative oral addiction habits showed significantly lower
QOL scores for activity (48.08 ± 16.01 versus 72.28 ± 26.99) and recreation (57.69 ± 35.92 versus
78.26 ± 31.89) domains (p-value: 0.004 and 0.044, respectively).
When assessed for effect of the number of treatment modalities received by the patients, there
was a decrease in mean scores of almost all domains but statistical significance was observed
for anxiety domain only (p-value: 0.004) (Table 5).
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Domain Surgery Alone [n =10] [Mean ± SD]
Surgery and Radiotherapy [n
= 46] [Mean ± SD]
Surgery, Radio and Chemotherapy
[n = 3] [Mean ± SD]
p-
value
Pain 82.5 ± 16.87 78.8 ± 18.23 75 ± 0 0.764
Appearance 72.5 ± 21.89 71.2 ± 29.33 50 ± 25 0.439
Activity 67.5 ± 23.72 64.67 ± 26.65 41.67 ± 14.43 0.301
Recreation 55 ± 34.96 74.46 ± 30.95 41.67 ± 28.87 0.070
Swallowing 72.5 ± 34.26 66.85 ± 34.18 41.67 ± 38.19 0.397
Chewing 50 ± 33.33 38.04 ± 31.95 16.67 ± 28.87 0.271
Speech 72.5 ± 27.51 67.93 ± 21.51 58.33 ± 14.43 0.622
Shoulder 82.5 ± 20.58 76.09 ± 24.13 50 ± 43.3 0.141
Taste 85 ± 17.48 68.48 ± 27.61 50 ± 43.3 0.097
Saliva 75 ± 20.41 53.8 ± 37.63 66.67 ± 14.43 0.207
Mood 65 ± 29.34 60.33 ± 26.13 33.33 ± 14.43 0.189
Anxiety 77.5 ± 18.45 80.98 ± 17.63 41.67 ± 38.19 0.004*
TABLE 5: Comparison of Quality of Life Domains by Treatment Modalities
We also assessed the effect of follow-up duration on QOL scores in different domains. We
observed that the scores for chewing, swallowing, taste, and appearance were the lowest in
patients with a follow-up duration of less than one year, while scores for speech, saliva, mood,
and anxiety were highest in these patients. However, these differences in scores on the basis of
follow-up duration were not statistically significant (Table 6).
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Domain ≤1 year [n = 9] [Mean ±SD]
>1-2 years [n = 16] [Mean ±
SD]
>2 years [n = 34] [Mean ±
SD] p-value
Pain 80.56 ± 20.83 78.13 ± 20.16 83.82 ± 16.15 0.649
Appearance 58.33 ± 25 71.88 ± 25.62 79.41 ± 25.72 0.073
Activity 61.11 ± 22.05 73.44 ± 24.95 65.44 ± 28.88 0.482
Recreation 66.67 ± 33.07 79.69 ± 33.19 72.79 ± 34.47 0.436
Swallowing 58.33 ± 46.77 60.94 ± 41.8 71.32 ± 37.5 0.651
Chewing 22.22 ± 36.32 34.38 ± 35.21 45.59 ± 37.67 0.190
Speech 83.33 ± 21.65 68.75 ± 33.54 75 ± 26.83 0.565
Shoulder 69.44 ± 34.86 90.63 ± 15.48 77.21 ± 29.75 0.174
Taste 52.78 ± 42.29 73.44 ± 28.09 74.26 ± 35.08 0.254
Saliva 61.11 ± 37.73 53.13 ± 41.71 57.35 ± 43.31 0.899
Mood 69.44 ± 37.03 59.38 ± 30.1 64.71 ± 28.28 0.604
Anxiety 80.56 ± 32.54 79.69 ± 29.18 79.41 ± 30.45 0.987
TABLE 6: Comparison of Quality of Life Domains by Follow-up Duration
When divided on the basis of patient’s age, no significant difference of QOL scores was
observed for any domain.
On HR-QOL and G-QOL scales, a majority of the patients responded as fair, good, very good or
outstanding (88% and 91.5%, respectively). Chewing and swallowing were the two major
problems faced by the patients in the last seven days. Mood and anxiety were the least
frequently described issues in our study group. More than half (57.6%) of the patients did not
experience any issues in the last seven days (Figure 2).
FIGURE 2: Most important issues experienced by patients in
last seven days.
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Discussion
The assessment of QOL is a complex issue involving the evaluation of different domains such as
speech, pain, chewing, etc. As the outcome entails multiple factors, alternative study designs
could include multivariate assessments of QOL domains. The UW-QOL questionnaire has
already been validated by studies comparing the results of its application with those obtained
from other well-established questionnaires in the same field of study. Besides effectively
assessing QOL, the UW-QOL was well accepted by respondents and appraised as a reliable,
practical, and low-cost instrument for surveying the functional status of patients with head
and neck cancer [11]. However, the feasibility of its use in different languages still demands
further research.
The salient feature of this study is that it highlights the factors affecting the QOL in post-
operative OSCC patients. Few studies have described QOL issues in OSCC patients as a select
group. Most often oral QOL issues are brought to the limelight as a subgroup of diverse head
and neck cancers. Subsequently, issues related to OSCC are overwhelmed by general issues
faced by head and neck cancer patients.
Male predominance seen in the participants of this study is in concordance with existing
studies [12-19]. Mean patient’s age in our study (47.9 ± 12.7 years) was younger than mean
patients’ age reported by several studies [12-14,16,19]. Male patients were slightly elder (mean
± SD: 48.5 ± 12.2 years) than the female patients (mean ± SD: 45.4 ± 12.1 years) but this
difference was statistically insignificant (p = 0.536).
The overall mean QOL score in our study was 68.2 ± 24.7 and it was lower than the mean QOL
score (74.6 ± 18.2) of the study by Bhanja et al. [20]. Mean domain scores of each component
were measured using UW-QOL scale and the problems related to chewing (38.98 ± 32.25), saliva
(58.1 ± 35.18), and mood (59.8 ± 26.6) had minimum scores in our study. Similarly, in the study
by Nagy et al. [14] and Andrade et al. [21], the major problem faced by the patients was also
chewing. However, Rogers et al. [22] reported that 45% of patients in his study did not
experience any chewing problem. Similarly, Bhanja et al. [20] also reported mood and anxiety as
the major problems with mean values 46.5 ± 23.7 and 56.4 ± 26.9, respectively. These
observations reinforce the importance of dental rehabilitation of patients subjected to surgical
resection of OSCC. Speech impairment has been highlighted to be a concern for OSCC patients
in some previous studies, but we observed good scores for speech in our study [11-14].
Overall mean composite QOL score of cheek tumor patients in our study (70.9 ± 17.65) was
comparable to the mean QOL score of cheek tumor patients in the Bhanja et al. [20] study.
Overall mean composite QOL score of patients with tongue tumors was significantly lower than
scores of patients with cheek tumors in this study (p = 0.029). The difference in scores of pain,
swallowing, mood, and anxiety domains between these two groups can be explained by
increased innervation and the critical role of tongue in swallowing.
Problems like chewing, swallowing, taste, saliva, appearance were experienced to a greater
extent in late-stage tumors and can be attributed to extensive surgery. In addition, these
patients also receive adjuvant radiotherapy and/or chemotherapy which can cause fibrosis
leading to difficulty in chewing, salivation, and disfigurement. Nausea, vomiting, weakness,
and other side effects related to chemotherapy may also contribute to anxiety, mood
disturbances, and lack of recreation in these patients receiving adjuvant treatment. This
hypothesis is also favored by decreasing mean composite QOL scores with increasing
modalities.
Patients with restricted mouth opening experienced more pain and difficulty in the speech
which can be attributed to fibrosis and difficulty in mouth opening. Anxiety, lack of
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recreational activity, and the sense of poor appearance might partially be explained by the
psychological impact of the disease.
Regarding HR-QOL and G-QOL, chewing, swallowing, activity, appearance, saliva, and pain
were some of the important issues of patients in the last week before filling the questionnaire.
These issues have also been highlighted in some of the previously reported studies [20-21].
Several studies have described the post-treatment evaluation of HR-QOL for OSCC patients and
assessed factors associated with improvements in prognosis. These studies reinforce the
hypothesis that patients who survived surgery may effectively improve and even recover their
HR-QOL levels, at least to pre-operative ratings [11,14,19,23-24]. The improvement of certain
QOL domain scores with increasing follow up duration, as seen in our study, points to the fact
that cancer patients in the initial years of follow up experience psychological stress and post-
treatment effects of different treatments they receive. These problems settle down with time
and therefore, these patients need proper psychological counseling and support.
In the light of our findings, we think that patients with late-stage tumors and tongue tumors
should be actively managed for pain. There should be special education and physical training
for these patients to improve their mouth opening, chewing, speech, and swallowing. The use
of liquid and semisolid diet in the initial post-operative period will also help in reducing these
complaints. These patients should also get special counseling from a psychiatrist for their
anxiety and mood problems.
Main limitations of this study are small sample size and single-center experience. In addition,
self-reporting of the questionnaire by the patients bear the potential of over and/or
underestimation. Multi-center studies on a larger cohort of patients are required to address the
issues of postoperative QOL. Furthermore, prospective studies should be carried out to assess
the role of interventions done to improve QOL.
Conclusions
Post-treatment QOL assessment of OSCC patients reveals a number of problems such as
chewing, swallowing, saliva, lack of activity, mood disturbances, etc. Pre-operative clinical
features including tumor site, tumor stage, and extent of mouth opening have a significant
impact on post-treatment problems in different ways. Proper and timely interventions help in
achieving better QOL levels early and closer to pre-operative levels.
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